22:27 IST
NSE
Management Change
Mankind Pharma Management Change
Mankind Pharma announced the cessation of Mr. Bharat Anand as an Independent Director, effective August 30, 2026, upon the completion of his second term.
Mankind Pharma Ltd
- Share price
- ₹2,500.00
- Market cap
- ₹1,03,261 Cr
- Revenue (annual)
- ₹14,278 Cr
- Net profit (annual)
- ₹1,913 Cr
- P/E (TTM)
- 50.5×Sector 47.3×
- Promoter holding
- 72.63%-0.03% QoQ
- FII holding
- 9.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 10Employee Stock Options 6Other Announcement 5Annual General Meeting 5Management Change 4Earnings Call 4Financial Results 3Debt & Borrowing 3Results Update 2Credit Rating 2Board Meeting Date 2Share Pledge 1Partnership 1Business Update 1Acquisition 1
Time
4 announcements with these filters
16:10 IST
BSE
Management Change
Mankind Pharma Management Change
Mankind Pharma has appointed Mr. Anish Vanraj Bafna as an Additional Director (Non-Executive Independent Director), effective August 10, 2026.
22:22 IST
BSE
Management Change
Mankind Pharma Management Change
Mankind Pharma appointed Nilesh Kulkarni as Head of HR and Senior Management Personnel. Prateek Dubey transitions to new responsibilities, effective June 8, 2026, amid organizational restructuring.
19:47 IST
NSE
Management Change
Mankind Pharma Management Change
Mankind Pharma announced the re-appointment of WTD Satish Kumar Sharma and the resignation of SMP Pramod Gokhale. These changes reflect standard corporate governance and leadership transitions.